4//SEC Filing
Poirier Michael S. 4
Accession 0001493152-20-010825
CIK 0001460702other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 9:26 PM ET
Size
5.4 KB
Accession
0001493152-20-010825
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Award
Stock Option (Right to Buy)
2020-06-06+1,000,000→ 1,000,000 totalExercise: $5.13Exp: 2030-06-06→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
Documents
Issuer
Qualigen Therapeutics, Inc.
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001812504
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 9:26 PM ET
- Size
- 5.4 KB